According to Chugai Pharmaceutical's latest financial reports and stock price the company's current Operating Margin is 46.38%. At the end of 2024 the company had an Operating Margin of 46.39%.
Year | Operating Margin | Change |
---|---|---|
2024 | 46.39% | 16.16% |
2023 | 39.93% | -5.29% |
2022 | 42.17% | 0.52% |
2021 | 41.95% | 10.71% |
2020 | 37.89% | 25.07% |
2019 | 30.30% | 44.64% |
2018 | 20.95% | 15.32% |
2017 | 18.16% | 19.98% |
2016 | 15.14% | -13.47% |
2015 | 17.50% | 5.92% |
2014 | 16.52% | -9.05% |
2013 | 18.16% | -3.4% |
2012 | 18.80% | 22.92% |
2011 | 15.30% | -11.63% |
2010 | 17.31% | -16.97% |
2009 | 20.85% | 8% |
2008 | 19.30% | 0.19% |
2007 | 19.27% | -0.21% |
2006 | 19.31% | -26.7% |
2005 | 26.34% | 35.01% |
2004 | 19.51% | -7.79% |
2003 | 21.16% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.